Jennifer Barrett, Associate Editor

Over a 6-year period, the analysis mapped out drugs cost patterns for the 49 top-selling brand-name medications in the United States based on pharmacy claims data from a health insurance database.

Episodic cluster headaches represent 85% to 90% of cluster headache prevalence, with approximately 250,000 adults living with the condition in the United States.

This approval marks the first generic naloxone nasal spray for use in a community setting by an individual without medical training.

To be eligible for dolutegravir and lamivudine, patients must have no history of antiretroviral therapy (ART) and no known or suspected substitutions associated with resistance to the individual components of the regimen.

THE FDA has approved cladribine (Mavenclad, EMD Serono), a new oral treatment for relapsing forms of multiple sclerosis (MS) in adults including relapsing-remitting disease and active secondary progressive disease.

Dupilumab (Dupixent, Regeneron and Sanofi) would be the first FDA-approved biologic for the treatment of severe chronic rhinosinusitis with nasal polyps.

The latest proposed rule, which was announced by Health and Human Services (HHS) Secretary Alex Azar and Inspector General Daniel Levinson, targets backdoor rebates by encouraging manufacturers to pass discounts directly to patients.

According to a recent report, spending on insulin per patient nearly doubled between 2012 and 2016 in the United States, which the researchers determined was largely driven by price hikes.

Officials with the FDA today approved the first generic version of vigabatrin 500-mg tablets, which is also sold under the brand name Sabril, a medication used to treat complex partial seizures.

Officials with the FDA have approved romiplostim (NPLATE, Amgen) for the treatment of immune thrombocytopenia (ITP) in pediatric patients aged 1 year and older.

CVS Health announced that it has closed its acquisition of Aetna with the promise to transform the consumer health experience.

New research suggests that hepatitis C virus treatments can be shortened in half of patients receiving them without compromising efficacy, potentially leading to significant cost savings.

The Department of Justice today granted conditional approval to the $69 billion merger between CVS Health Corporation and Aetna Inc.

Older women undergoing chemotherapy for breast cancer have a higher risk of experiencing a decline in their ability to function physically, according to a new study.

The approvals of Delstrigo and Pifeltro are based on findings from 2 phase 3 clinical trials.

Heavy alcohol consumption at an early age may be linked to a 3-fold increased risk of being diagnosed with high-grade prostate cancer, according to a new study.

US life expectancy rates are dropping, while trends show a surge in young adult and midlife mortality, according to recent studies.

Rheumatoid arthritis the most common type of arthritis, is believed to be triggered by a mix of environmental and genetic factors.

The benefits of transplanting kidneys from donors with hepatitis C virus (HCV) may outweigh the risks for individuals in need of a lifesaving organ transplant, according to a new study.

Silvestrol, an active substance formed by 400 different types of mahogany plants, may be key to developing a potential cure for hepatitis E virus.

Advancements in breast cancer treatment have improved survival rates, but financial hardships related to the cost of these lifesaving therapies can weigh heavily on patients.

Diabetes significantly raises the risk of developing cancer, especially in women, according to a newly published study.

Survivors of cancer in adolescence and young adulthood may be at higher risk for endocrine diseases, such as thyroid disease, testicular dysfunction, and diabetes, according to a recent study published in JAMA.

Officials with the FDA are requiring safety label updates for fluoroquinolone antibiotics due to risks of mental health adverse effects, and blood sugar disturbances.

Tonsil and adenoid removal surgery during childhood increases the long-term risk of respiratory, allergic, and infectious diseases, according to a recent study.

Hospital-acquired antibiotic-resistant infection is on the rise among children across the United States, putting those with chronic conditions at higher risk of infection.

Recently-published research suggest that medical cannabis use may be associated with a higher risk of abusing prescription medication, including pain relievers.

Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis (MS) in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.

Cancer outcomes may be worse for patients with a positive screening result who wait longer for diagnostic testing, according to newly published research.